mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |